Tobias Knorr

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
For decades, researchers have been developing a range of promising strategies in bone tissue engineering with the aim of producing a significant clinical benefit over existing therapies. However, a major problem concerns the traditional use of xenogeneic substances for the expansion of cells, which complicates direct clinical transfer. The study's aim was(More)
  • 1